EverCross™ AB35W05100135 (UDI 00763000184223)Recalls & reported problems
Ev3, Inc · PTA AB35W05100135 EVERCROSS 035 V09 · Class 2
All models of EverCross (114)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000184223), received between Nov 5, 2019 and Mar 13, 2020 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Burst Container or Vessel” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Burst Container or Vessel2
- Inflation Problem2
- Leak/Splash1
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 13, 2020Burst Container or Vessel; Inflation Problem; Burst Container or Vessel; Inflation Problem
PHYSICIAN INTENDED TO USE AN EVERCROSS PTA BALLOON FOR TREATMENT OF THE A CALCIFIED AND PLAQUE LESION IN THE PATIENT¿S MID SUPERFICIAL FEMORAL ARTERY (SFA). MODERATE VESSEL TORTUOSITY AND SEVERE CALCIFICATION ARE REPORTED. LESION EXHIBITED 70% STENOSIS. A NON-MEDTRONIC INFLATION DEVICE WAS USED FOR BALLOON INFLATION. PRE-DILATION WAS PERFORMED. NO DAMAGE NOTED TO PACKAGING PRIOR TO SUE. NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE PACKAGING. IFU WAS FOLLOWED AND THE DEVICE WAS PREPPED WITHOUT ISSUE. THE DEVICE WAS NOT PASSED THROUGH A PREVIOUSLY DEPLOYED STENT AND NO RESISTANCE WAS ENCOUNTERED DURING ADVANCEMENT. IT IS REPORTED THAT THE BALLOON WAS INFLATED TO 5ATM AND THE BALLOON WAS NOT OBSERVED TO HAVE BEEN FILLING. THE PRESSURE PUMP WAS INCREASED TO 8ATM AND THE BALLOON STILL DID NOT APPEAR TO FILL. THE BALLOON WAS DEFLATED FOR WITHDRAWAL AND BLOOD WAS OBSERVED IN THE PRESSURE PUMP. THE BALLOON WAS WITHDRAWN FROM THE PATIENT AND A LONGITUDINAL BALLOON BURST WAS EVIDENT. A NON-MEDTRONIC BALLOON WAS USED TO COMPLETE THE PROCEDURE. NO INJURY REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9829080 ↗MalfunctionNov 5, 2019Burst Container or Vessel; Inflation Problem; Leak/Splash; Burst Container or Vessel; Inflation Problem; Leak/Splash
PHYSICIAN INTENDED TO USE AN EVERCROSS PTA BALLOON DURING TREATMENT OF A 100MM PLAQUE LESION IN THE PATIENT¿S MID SUPERFICIAL FEMORAL ARTERY (SFA). VESSEL DIAMETER REPORTED AS 4-7MM. MODERATE VESSEL CALCIFICATION AND TORTUOSITY ARE REPORTED. LESION EXHIBITED 80% STENOSIS. NO ISSUES NOTED TO PACKAGING PRIOR TO USE. NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE PACKAGING. IFU WAS FOLLOWED. THE DEVICE WAS PREPPED WITHOUT ISSUE. PRE-DILATION WAS PERFORMED USING TWO BALLOONS. A NON-MEDTRONIC INFLATION DEVICE WAS USED. THE DEVICE WAS NOT PASSED THROUGH A PREVIOUSLY DEPLOYED STENT. NO RESISTANCE WAS ENCOUNTERED DURING ADVANCEMENT. WHEN THE BALLOON REACHED THE TARGET AREA, THE BALLOON WAS ATTEMPTED TO BE INFLATED. IT IS REPORTED THAT BALLOON INFLATION WAS NOT OBVIOUS, AND THE PRESSURE PUMP DID NOT MOVE. THE PHYSICIAN WITHDREW THE BALLOON. BLOOD WAS OBSERVED IN THE PRESSURE PUMP. A LEAK IN THE BALLOON WAS ALSO OBSERVED. NO BALLOON FRAGMENTATION REPORTED. THE DEVICE WAS REPLACED TO COMPLETE THE PROCEDURE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9278075 ↗
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page